Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Change in Accured Expenses (2019 - 2025)

aTYR PHARMA's Change in Accured Expenses history spans 7 years, with the latest figure at -$536000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 164.97% year-over-year to -$536000.0; the TTM value through Dec 2025 reached -$33000.0, up 97.54%, while the annual FY2025 figure was -$33000.0, 97.54% up from the prior year.
  • Change in Accured Expenses reached -$536000.0 in Q4 2025 per ATYR's latest filing, down from $18000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $4.8 million in Q2 2025 to a low of -$4.3 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $433900.0, with a median of $198000.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 935.0% in 2022, then plummeted 11097.37% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $180000.0 in 2021, then surged by 935.0% to $1.9 million in 2022, then soared by 81.86% to $3.4 million in 2023, then crashed by 75.65% to $825000.0 in 2024, then plummeted by 164.97% to -$536000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Change in Accured Expenses are -$536000.0 (Q4 2025), $18000.0 (Q3 2025), and $4.8 million (Q2 2025).